Chinese english Germany Japanese Korea

5-(cyclopropylcarbonyl)-4,4-dimethyl-4,5-dihydro-1H-[1,2]dithiolo[3,4-c]quinoline-1-thione

5-(cyclopropylcarbonyl)-4,4-dimethyl-4,5-dihydro-1H-[1,2]dithiolo[3,4-c]quinoline-1-thione Struktur
325742-50-5
CAS-Nr.
325742-50-5
Englisch Name:
5-(cyclopropylcarbonyl)-4,4-dimethyl-4,5-dihydro-1H-[1,2]dithiolo[3,4-c]quinoline-1-thione
Synonyma:
5-(cyclopropylcarbonyl)-4,4-dimethyl-4,5-dihydro-1H-[1,2]dithiolo[3,4-c]quinoline-1-thione;cyclopropyl(4,4-dimethyl-1-thioxo-1,4-dihydro-5H-[1,2]dithiolo[3,4-c]quinolin-5-yl)methanone;Methanone, cyclopropyl(1,4-dihydro-4,4-dimethyl-1-thioxo-5H-[1,2]dithiolo[3,4-c]quinolin-5-yl)-
CBNumber:
CB42027452
Summenformel:
C16H15NOS3
Molgewicht:
333.49
MOL-Datei:
325742-50-5.mol
Request For Quotation

5-(cyclopropylcarbonyl)-4,4-dimethyl-4,5-dihydro-1H-[1,2]dithiolo[3,4-c]quinoline-1-thione Eigenschaften

Siedepunkt:
579.6±60.0 °C(Predicted)
Dichte
1.46±0.1 g/cm3(Predicted)
pka
-1.23±0.40(Predicted)

Sicherheit

5-(cyclopropylcarbonyl)-4,4-dimethyl-4,5-dihydro-1H-[1,2]dithiolo[3,4-c]quinoline-1-thione Chemische Eigenschaften,Einsatz,Produktion Methoden

5-(cyclopropylcarbonyl)-4,4-dimethyl-4,5-dihydro-1H-[1,2]dithiolo[3,4-c]quinoline-1-thione Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

5-(cyclopropylcarbonyl)-4,4-dimethyl-4,5-dihydro-1H-[1,2]dithiolo[3,4-c]quinoline-1-thione Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
VITAS-M LABORATORY, LTD. --
 Russia 6754 64
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6178 60
Specs --
 info@specs.net The Netherlands 6835 70
  • 5-(cyclopropylcarbonyl)-4,4-dimethyl-4,5-dihydro-1H-[1,2]dithiolo[3,4-c]quinoline-1-thione
  • cyclopropyl(4,4-dimethyl-1-thioxo-1,4-dihydro-5H-[1,2]dithiolo[3,4-c]quinolin-5-yl)methanone
  • Methanone, cyclopropyl(1,4-dihydro-4,4-dimethyl-1-thioxo-5H-[1,2]dithiolo[3,4-c]quinolin-5-yl)-
  • 325742-50-5
  • C16H15NOS3
Copyright 2019 © ChemicalBook. All rights reserved